MS mid term

Medication and Intravenous Calculations

• Dimensional Analysis and Dosing Principles:

  • Oral and injectable drug dosage calculations follow the core dimensional analysis formula:         $\text{Prescribed Dose} \div \text{Available Dose} \times \text{Available Quantity} = \text{Administered Dose}$
  • Alternatively, setup via standard dimensional analysis conversion factors:         $\text{Ordered Dose} \times \frac{\text{Quantity of Drug Vehicle}}{\text{Stock Dose Strength}} = \text{Volume or Number of Tablets to Administer}$

• Essential Unit Conversions:

  • Weight: $1\,\text{kg} = 2.2\,\text{lb}$
  • Weight (Metric): $1\,\text{g} = 1{,}000\,\text{mg}$; $1\,\text{mg} = 1{,}000\,\mu\text{g}$
  • Time: $1\,\text{hour} = 60\,\text{minutes}$

• Infusion Rate Formulas:

  • Electronic Infusion Pump Rate (Volumetric):$\text{Rate}\,(\text{mL/hr}) = \frac{\text{Total Volume}\,(\text{mL})}{\text{Total Time}\,(\text{hours})}$
  • Gravity Flow Rate (Manual Drip):$\text{Flow Rate}\,(\text{gtt/min}) = \frac{\text{Total Volume}\,(\text{mL}) \times \text{Drop Factor}\,(\text{gtt/mL})}{\text{Time}\,(\text{minutes})}$

• Administration Safety Checks:

  • Assess mathematical reasonableness prior to preparation (e.g., verifying that an oral dose does not require an unusually large number of tablets or that an infusion rate matches physiologic tolerances).
  • Apply standard rounding rules (drops per minute [$\text{gtt/min}$] must always be rounded to the nearest whole integer, as partial drops cannot be delivered mechanically; pump rates in $\text{mL/hr}$ are rounded to the nearest whole number or tenth per facility protocol).
  • Confirm units of measurement and patient-specific safety parameters (allergies, organ clearance function, weight-based limits) before administration.

• Worked Clinical Calculation Examples:

  • Example 1 (Oral Dosing): A medication order is $750\,\text{mg}$; supply is $250\,\text{mg/tablet}$. How many tablets are required?         $\text{Tablets to Administer} = \frac{750\,\text{mg}}{250\,\text{mg/tablet}} = 3\,\text{tablets}$
  • Example 2 (Pump Infusion Rate): A $1{,}000\,\text{mL}$ infusion is ordered over $8\,\text{hours}$. Calculate the pump rate.         $\text{Pump Rate}\,(\text{mL/hr}) = \frac{1{,}000\,\text{mL}}{8\,\text{hours}} = 125\,\text{mL/hr}$

Intravenous Fluid Replacement and Tonicity

• Fluid Classifications and Cellular Morphologic Effects:

  • Isotonic Solutions ($0.9\%\,\text{Saline}$ / Normal Saline, Lactated Ringer's):
    • Possess an osmolality approximating normal blood plasma ($275\text{--}295\,\text{mOsm/kg}$\,fluid).
    • Remain primarily within the extracellular fluid (ECF) compartment (intravascular and interstitial space).
    • Cause no net osmotic movement of water across the semipermeable cell membrane; erythrocyte size and intracellular volume remain unchanged.
  • Hypotonic Solutions ($0.45\%\,\text{Saline}$ / Half-Normal Saline, $0.33\%\,\text{Saline}$):
    • Possess an effective osmolality lower than blood plasma ($< 275\,\text{mOsm/kg}$\,fluid).
    • Lower serum osmolarity, causing free water to shift out of the intravascular space down its osmotic gradient and into the intracellular fluid (ICF).
    • Result in cellular hydration and swelling; prolonged or excessive administration risks cellular lysis.
  • Hypertonic Solutions ($3\%\,\text{Saline}$, $5\%\,\text{Saline}$, $50\%\,\text{Dextrose}$):
    • Possess an osmolality significantly higher than blood plasma ($> 295\,\text{mOsm/kg}$\,fluid).
    • Draw water from the intracellular space into the hypertonic intravascular and extracellular compartments.
    • Result in cellular shrinkage (crenation) and rapid expansion of intravascular volume.

• Metabolic Behavior of $5\%\,\text{Dextrose in Water}$ (D5W):

  • D5W is chemically isotonic in the intravenous container ($\approx 252\,\text{mOsm/L}$).
  • Once infused intravenously, the dextrose is rapidly transported into cells and metabolized into energy, carbon dioxide, and water.
  • Following rapid metabolism of the solute, the remaining hypotonic free water distributes throughout all fluid compartments, behaving physiologically as a hypotonic fluid in vivo.

• Colloid Dynamics and Albumin:

  • Albumin is a major plasma protein colloid that does not readily cross intact capillary membranes.
  • Administered intravenous albumin increases intravascular oncotic (colloid osmotic) pressure.
  • This gradient pulls water from the interstitial and third spaces into the vascular bed, rapidly expanding circulating plasma volume without requiring large crystalloid fluid loads.

• Complications of Fluid Administration:

  • Fluid Overload and Pulmonary Edema: Excessive crystalloid infusion expands intravascular hydrostatic pressure, forcing fluid across pulmonary capillary membranes into the alveoli. Signs include bibasilar crackles, dyspnea, orthopnea, tachypnea, cough with frothy pink sputum, jugular venous distention (JVD), and falling oxygen saturation.
  • Danger in Increased Intracranial Pressure (ICP): Hypotonic fluids ($0.45\%\,\text{Saline}$, D5W) are strictly contraindicated in patients with cerebral trauma, stroke, or elevated baseline ICP. Fluid shifts down the osmotic gradient into brain tissue, aggravating cerebral edema and causing life-threatening brain herniation.

• Clinical Analysis Examples:

  • Example 3 (Water Shifts in Hypotonic Administration): Water shifts across a cell membrane along its osmotic concentration gradient from the hypotonic extracellular fluid into the hypertonic intracellular environment, expanding intracellular volume and causing cellular swelling.
  • Example 4 (Indicators Warranting Immediate Reassessment): Acute onset of dyspnea, coughing, falling pulse oximetry ($\text{SpO}_2$), audible crackles upon pulmonary auscultation, peripheral pitting edema, bounding tachycardia, marked hypertension, or sudden neurological deterioration (confusion, restlessness) dictate immediate cessation of fluid infusion and urgent cardiopulmonary assessment.

Inflammation and Wound Healing

• Vascular and Hemodynamic Inflammatory Responses:

  • Vasodilation: Chemical mediators (histamine, prostaglandins, bradykinin) trigger relaxation of vascular smooth muscle, expanding local arteriolar diameter and blood flow. This produces localized erythema (redness/rubor) and warmth (heat/calor).
  • Increased Capillary Permeability: Endothelial cell retraction widens intercellular junctions, enabling protein-rich fluid (exudate) to escape the intravascular space into the interstitial spaces. This fluid accumulation directly causes localized swelling (edema/tumor) and mechanical tension on nerve endings, contributing to pain (dolor).

• Cellular Leukocyte Kinetics:

  • The early cellular response is characterized by leukocyte margination, rolling, adhesion, and migration (diapedesis/transmigration) through the vessel wall toward the site of tissue injury along a chemical gradient (chemotaxis).
  • Neutrophils: Function as the primary cellular first responders in acute bacterial inflammation, arriving within $6\text{--}24\,\text{hours}$. Neutrophils engage in active phagocytosis of bacteria, release antimicrobial enzymes, and generate reactive oxygen species before undergoing apoptosis and forming purulent debris.

• Healing Intentions:

  • Primary Intention: Occurs in clean surgical wounds with well-approximated skin edges joined by sutures, staples, or adhesive strips. Healing occurs rapidly with minimal granulation tissue formation, low risk of infection, and fine scar formation.
  • Secondary Intention: Occurs in wounds involving extensive tissue loss, irregular margins, or contamination (e.g., pressure ulcers, open infected wounds). Edges cannot be approximated; the defect must heal from the base upward through extensive granulation tissue formation, wound contraction, and re-epithelialization, resulting in larger, noticeable scars.
  • Tertiary Intention (Delayed Primary Closure): Indicated for heavily contaminated or potentially infected wounds that are intentionally left open initially to allow drainage and reduction of bioburden, followed by delayed surgical closure once inflammation and bacterial loads subside.

• Systemic and Local Factors Delaying Wound Healing:

  • Hypoperfusion, arterial insufficiency, or chronic tissue hypoxia.
  • Protein-calorie malnutrition and deficiencies in zinc, vitamin A, and vitamin C (which impairs collagen synthesis).
  • Uncontrolled diabetes mellitus and persistent hyperglycemia (which impairs leukocyte function and microvascular perfusion).
  • Pharmacologic immunosuppression (chronic systemic corticosteroid therapy).
  • Wound infection, heavy necrotic tissue burden, hematoma, or mechanical tension across the wound line.

• Clinical Analysis Examples:

  • Example 5 (Mechanism of Classic Local Inflammatory Signs): Mediated by chemical signaling: arteriolar vasodilation drives localized hyperemic blood flow to produce erythema and warmth; increased endothelial permeability causes plasma exudation into tissue to produce swelling; chemical stimulation of nociceptors coupled with swelling-induced tissue pressure yields pain; localized pain and tissue tumefaction combine to produce loss of function (functio laesa).
  • Example 6 (Surgical Incision Warning Signs): Prompt surgical evaluation is warranted by purulent (thick, cloudy, yellow/green, malodorous) drainage, spreading erythema extending beyond the immediate margin ($> 1\text{--}2\,\text{cm}$), increasing localized edema or induration, warmth, separation of incision edges, unmanageable or escalating pain, and systemic manifestations such as fever ($> 38^{\circ}\text{C}$ / $100.4^{\circ}\text{F}$) or peripheral leukocytosis.

Perioperative Nursing Care

• Immediate Post-Anesthesia Care Unit (PACU) Prioritization:

  • Assessments follow the systematic Airway, Breathing, and Circulation (ABC) hierarchy.
  • Airway: Verify patency and absence of stridor, snoring, or mechanical obstruction.
  • Breathing: Evaluate respiratory rate, depth, bilateral symmetric chest excursion, auscultate lung sounds, and continuously verify pulse oximetry.
  • Circulation: Monitor heart rate, blood pressure, peripheral perfusion, capillary refill, skin temperature, and check surgical dressings and drainage devices for active hemorrhage.

• Surgical Wound Separation Emergencies:

  • Wound Dehiscence: Partial or complete separation of the outer fascial or cutaneous margins of a surgical wound without organ protrusion.
  • Wound Evisceration: Total separation of all surgical wound layers accompanied by the protrusion of internal visceral contents (typically abdominal bowel loops) through the incision opening.
  • Emergency Nursing Response to Evisceration:
    • Stay with the patient; immediately call for emergency assistance and notify the attending surgeon.
    • Position the patient in a low-Fowler position ($15\text{--}30^{\circ}$) with knees and hips slightly bent to minimize intra-abdominal wall tension.
    • Cover the exposed visceral organs immediately with sterile gauze or towels saturated with warm, sterile $0.9\%\,\text{Sodium Chloride}$ solution to prevent tissue desiccation and necrosis; do not attempt to push organs back into the abdominal cavity.
    • Maintain strict NPO (nil per os) status in anticipation of immediate return to the operating room.
    • Monitor vital signs continuously for signs of hemodynamic collapse or septic shock.

• Postoperative Pulmonary and Vascular Prophylaxis:

  • Atelectasis Prevention: Implement deep breathing, controlled coughing maneuvers, early progressive ambulation, and sustained maximal inspiration using incentive spirometry ($10\,\text{times/hour}$ while awake) to re-expand collapsed terminal alveoli.
  • Venous Thromboembolism (VTE) / Deep Vein Thrombosis (DVT) Prevention: Implement early ambulation, properly fitted sequential compression devices (SCDs), graduated compression stockings, intermittent active ankle-pumping exercises, adequate hydration, and pharmacological prophylaxis (subcutaneous low-molecular-weight heparin or unfractionated heparin).

• Preoperative Safety Assessments and Complications:

  • Assess for drug, latex, and antiseptic allergies prior to medication administration.
  • Screen patient history for previous adverse anesthetic reactions (e.g., family history of malignant hyperthermia), coagulopathies, and use of antiplatelet or anticoagulant agents.
  • Anticipate common postoperative complications: hypothermia, urinary retention, postoperative nausea and vomiting (PONV), ileus, and hypoxemia.

• Clinical Analysis Examples:

  • Example 7 (Snoring and Desaturating Patient): Snoring indicates upper airway occlusion, typically caused by posterior relaxation of the tongue against the pharyngeal wall under residual sedation. The nurse must immediately intervene on the Airway by executing a head-tilt/chin-lift or jaw-thrust maneuver, stimulating the patient, positioning the patient on their side (if not contraindicated), and administering supplemental oxygen while assessing the need for an oral or nasopharyngeal airway.
  • Example 8 (Atelectasis vs. DVT Prophylaxis Comparison): Atelectasis prevention centers on restoring pulmonary alveolar volume and gas exchange (incentive spirometry, coughing, deep breathing), whereas DVT prevention focuses on eliminating venous stasis and counteracting hypercoagulability in the peripheral venous system (SCDs, venous stockings, anticoagulant administration). Both conditions are jointly mitigated by early, progressive postoperative ambulation.

Fluid, Electrolyte, and Acid-Base Imbalances

• Fluid Balance Assessment:

  • Serial daily weights obtained at the same time every morning, on the same calibrated scale, with identical clothing, after voiding provide the most sensitive index of total body fluid shifts:         $1\,\text{kg of body weight change} = 1{,}000\,\text{mL}\,(1\,\text{L})\,\text{of fluid retained or lost}$
  • Continuous intake and output ($\text{I/O}$) documentation tracks fluid volume status trends.

• Sodium Disturbances and Neurologic Vulnerability:

  • Hyponatremia ($< 135\,\text{mEq/L}$): Hypoosmolar state drives water into cerebral neurons. Clinical signs: headache, lethargy, confusion, nausea, muscle twitching, cerebral edema, seizures, coma, and herniation.
  • Hypernatremia ($> 145\,\text{mEq/L}$): Hyperosmolar state draws water out of brain cells, resulting in cellular dehydration. Clinical signs: intense thirst, dry mucous membranes, agitation, restlessness, hallucinations, lethargy, and seizures.

• Potassium Disturbances and Cardiac Electrophysiology:

  • Hypokalemia ($< 3.5\,\text{mEq/L}$):
    • Etiologies: Loop/thiazide diuretic therapy without replacement, excessive vomiting, nasogastric suction, diarrhea, hyperaldosteronism, intracellular shifts via insulin or alkalosis.
    • Neuromuscular Signs: Generalized muscle weakness, hyporeflexia, paresthesias, muscle cramping, constipation, paralytic ileus.
    • ECG / Arrhythmia Risk: Flattened or inverted T waves, ST-segment depression, prominent U waves, ventricular ectopy, and increased susceptibility to digitalis toxicity.
    • Nursing Priorities: Cardiac rhythm monitoring, oral or controlled intravenous potassium replacement (never administer potassium via IV push or bolus; standard concentration limits apply to peripheral lines).
  • Hyperkalemia ($> 5.0\,\text{mEq/L}$):
    • Etiologies: Acute or chronic renal failure, potassium-sparing diuretics, ACE inhibitors/ARBs, extensive tissue trauma/burns (cellular lysis), severe metabolic acidosis, hypoaldosteronism.
    • Neuromuscular Signs: Muscle weakness, ascending flaccid paralysis, paresthesias, hyperactive bowel sounds, intestinal colic.
    • ECG / Arrhythmia Risk: Tall, peaked T waves, prolonged PR interval, flattening or loss of P waves, widening of the QRS complex, sine-wave configuration, ventricular fibrillation, and asystole.
    • Nursing Priorities: Immediate continuous 12-lead ECG monitoring, administration of intravenous calcium gluconate (to stabilize myocardial cell membranes), rapid-acting regular insulin plus $50\%\,\text{Dextrose}$ (to shift potassium intracellularly), sodium polystyrene sulfonate or loop diuretics (for potassium elimination), or emergent hemodialysis.

• Calcium and Phosphate Homeostasis:

  • Hypocalcemia ($< 8.5\,\text{mg/dL}$):
    • Etiologies: Inadvertent surgical trauma or devascularization/removal of the parathyroid glands during thyroidectomy or parathyroidectomy; severe vitamin D deficiency; acute pancreatitis; chronic kidney disease.
    • Neuromuscular Signs: Neuromuscular excitability, circumoral numbness, paresthesias of fingertips, tetany, positive Chvostek's sign (ipsilateral facial twitching upon tapping the facial nerve anterior to the ear), positive Trousseau's sign (carpal spasm induced by inflating a blood pressure cuff above systolic pressure for $3\,\text{minutes}$), bronchospasm, laryngospasm, and prolonged QT interval.
  • Renal Effects on Phosphorus: In chronic renal disease, impaired glomerular filtration diminishes phosphate excretion, resulting in hyperphosphatemia. Because serum calcium and phosphorus maintain an inverse solubility product relationship ($\text{Ca}^{2+} \times \text{PO}_4^{3-}$), elevated serum phosphorus precipitates serum calcium, driving hypocalcemia.

• Arterial Blood Gas (ABG) Interpretation:

  • Normal Reference Ranges:
    • $\text{pH} = 7.35\text{--}7.45$
    • $\text{PaCO}_2 = 35\text{--}45\,\text{mm\,Hg}$
    • $\text{HCO}_3^- = 22\text{--}26\,\text{mEq/L}$
  • Systematic Interpretation Process:
    • Determine pH: $< 7.35$ denotes acidemia; $> 7.45$ denotes alkalemia.
    • Determine respiratory component ($\text{PaCO}_2$): $> 45\,\text{mm\,Hg}$ reflects respiratory acid accumulation; $< 35\,\text{mm\,Hg}$ reflects respiratory alkalosis.
    • Determine metabolic component ($\text{HCO}_3^-$): $< 22\,\text{mEq/L}$ reflects metabolic acidosis; $> 26\,\text{mEq/L}$ reflects metabolic alkalosis.
    • Identify the primary etiology by matching the parameter whose directional shift matches the pH change.

• Clinical Analysis Examples:

  • Example 9 (ABG Interpretation): Given values: $\text{pH} = 7.29$, $\text{PaCO}_2 = 55\,\text{mm\,Hg}$, $\text{HCO}_3^- = 25\,\text{mEq/L}$.
    • $\text{pH} = 7.29$ ($< 7.35$) denotes acidemia.
    • $\text{PaCO}_2 = 55\,\text{mm\,Hg}$ ($> 45\,\text{mm\,Hg}$) indicates respiratory acid retention (respiratory acidosis).
    • $\text{HCO}_3^- = 25\,\text{mEq/L}$ ($22\text{--}26\,\text{mEq/L}$) is within normal physiological limits (no renal compensation has occurred yet).
    • Interpretation: Uncompensated respiratory acidosis (commonly precipitated by hypoventilation, respiratory depression from anesthesia/opioids, or acute airway obstruction).
  • Example 10 (Urgency of Hyperkalemic Cardiac Assessment): Elevated potassium partially depolarizes the myocardial resting membrane potential, altering cardiac conductivity, shortening repolarization, and lowering the threshold for lethal ventricular arrhythmias (ventricular fibrillation, asystole). Timely continuous cardiac monitoring and rapid intervention are required before hemodynamic arrest occurs.

Thyroid and Endocrine Disorders

• Hyperthyroidism versus Hypothyroidism Comparison:

  • Metabolic Rate: Hyperthyroidism exhibits a hypermetabolic state with accelerated energy expenditure; hypothyroidism exhibits a hypometabolic state with marked cellular slowing.
  • Temperature Tolerance: Hyperthyroidism presents with heat intolerance and diaphoresis; hypothyroidism presents with cold intolerance and hypothermia.
  • Body Weight: Hyperthyroidism manifests as unintended weight loss despite an increased appetite; hypothyroidism manifests as weight gain despite a poor appetite.
  • Heart Rate and Hemodynamics: Hyperthyroidism exhibits sinus tachycardia, palpitations, systolic hypertension, and high-output states; hypothyroidism exhibits sinus bradycardia, hypotension, and decreased stroke volume.
  • Bowel Elimination Patterns: Hyperthyroidism produces frequent bowel movements or diarrhea; hypothyroidism produces constipation and decreased peristalsis, with risk of fecal impaction.

• Hypothalamic-Pituitary-Thyroid Negative Feedback Axis:

  • Under physiologic conditions, thyrotropin-releasing hormone (TRH) from the hypothalamus stimulates the anterior pituitary to secrete thyroid-stimulating hormone (TSH), which prompts the thyroid gland to synthesize and release thyroxine (T4) and triiodothyronine (T3).
  • Elevated serum free T4 and free T3 inhibit pituitary TSH release via negative feedback.
  • Primary Hypothyroidism: Glandular failure of the thyroid results in low serum free T4, removing negative feedback inhibition on the pituitary and resulting in a compensatory elevation of serum TSH.
  • Primary Hyperthyroidism: Autonomous hypersecretion of free T4 from the thyroid gland produces continuous negative feedback at the anterior pituitary, suppressing serum TSH to low or undetectable levels.

• Acute Endocrine Emergencies:

  • Thyroid Storm (Thyrotoxic Crisis): An acute, life-threatening exacerbation of hyperthyroidism precipitated by physiological stress, trauma, surgery, or infection. Characterized by severe hyperpyrexia ($> 39^{\circ}\text{C}$ / $102.2^{\circ}\text{F}$), extreme sinus tachycardia or tachyarrhythmias, systolic hypertension, agitation, delirium, seizures, jaundice, and potential high-output cardiac collapse.
  • Myxedema Coma: Extreme, decompensated end-stage hypothyroidism. Characterized by severe hypothermia, progressive hypoventilation leading to respiratory acidosis, profound bradycardia, hypotension, non-pitting periorbital and pretibial edema (mucopolysaccharide deposits), hyponatremia, hypoglycemia, and progressive stupor deteriorating into coma.

• Adrenal Dysfunction Comparison:

  • Adrenal Insufficiency / Acute Adrenal Crisis (Addisonian Crisis):
    • Pathophysiology: Deficiency of glucocorticoids (cortisol) and mineralocorticoids (aldosterone).
    • Blood Pressure: Profound hypotension, postural orthostasis, and refractory hypovolemic vascular collapse.
    • Glucose Dynamics: Hypoglycemia due to impaired hepatic gluconeogenesis.
    • Electrolytes: Hyponatremia and hyperkalemia (due to aldosterone deficit).
    • Infection Risks: Susceptibility to severe physiological shock following infection; minor stressors can precipitate crisis.
  • Cushing Syndrome (Hypercortisolism):
    • Pathophysiology: Chronic excessive circulating levels of glucocorticoids.
    • Blood Pressure: Persistent hypertension secondary to salt and water retention and enhanced vascular sensitivity to catecholamines.
    • Glucose Dynamics: Impaired glucose tolerance and overt secondary hyperglycemia due to stimulated gluconeogenesis and peripheral insulin resistance.
    • Infection Risks: Profound suppression of cell-mediated immunity and anti-inflammatory mechanisms, leaving patients highly vulnerable to opportunistic infections while masking classic signs (such as fever and leukocytosis).

• Clinical Analysis Examples:

  • Example 11 (TSH / Free T4 Relationship in Primary Hypothyroidism): In primary hypothyroidism, the pathological process resides directly within the thyroid gland, which fails to synthesize adequate thyroid hormone, resulting in low serum free T4. The anterior pituitary attempts to stimulate the non-responsive thyroid gland by upregulating TSH secretion, producing an elevated TSH level paired with a depressed free T4 level.
  • Example 12 (Differentiating Endocrine Emergencies from Chronic Stable Disease): Chronic endocrine disease features gradual, insidious metabolic adaptations (e.g., mild fatigue, manageable weight changes, stable dry skin, or mild resting tachycardia). In contrast, an endocrine emergency manifests with sudden decompensation of autonomic and vital regulatory processes, characterized by hemodynamic instability (severe hypotension or uncontrolled tachyarrhythmias), core thermoregulatory collapse (extreme hyperthermia in thyroid storm or profound hypothermia in myxedema coma), acute mental status alterations (delirium, lethargy, stupor, coma), and severe metabolic/electrolyte disturbances.

Diabetes Mellitus, DKA, and HHS

• Hypoglycemia Recognition and Management:

  • Manifestations: Neurogenic/adrenergic symptoms (tremulousness, palpitations, diaphoresis, pallor, anxiety) and neuroglycopenic symptoms (confusion, lightheadedness, slurred speech, behavioral changes, visual disturbances, seizure, loss of consciousness).
  • Treatment in an Alert Patient (Intact Swallowing Reflex):
    • Administer $15\text{--}20\,\text{g}$ of rapid-acting simple carbohydrate (e.g., $4\,\text{oz}$ [$120\,\text{mL}$] of fruit juice, $4\,\text{oz}$ of regular non-diet soda, $3\text{--}4\,\text{glucose tablets}$, or $1\,\text{tablespoon}$ of sugar or honey).
    • Reassess capillary blood glucose after $15\,\text{minutes}$ (the Rule of 15).
    • If blood glucose remains $< 70\,\text{mg/dL}$, repeat the administration of $15\,\text{g}$ of simple carbohydrates and recheck in $15\,\text{minutes}$.
    • Once blood glucose normalizes, provide a complex carbohydrate and protein snack (e.g., peanut butter crackers) if the next scheduled meal is more than $1\,\text{hour}$ away.
  • Escalation: If the patient develops altered consciousness, swallowing impairment, or becomes unresponsive, escalate immediately to intravenous administration of $25\text{--}50\,\text{mL}$ of $50\%\,\text{Dextrose in Water}$ (D50W) or intramuscular/subcutaneous injection of $1\,\text{mg}$ glucagon.

• Comparison: Diabetic Ketoacidosis (DKA) versus Hyperosmolar Hyperglycemic State (HHS):

  • Patient Population: DKA predominantly occurs in Type 1 Diabetes Mellitus (can occur in Type 2 under severe stress); HHS occurs primarily in older adults with Type 2 Diabetes Mellitus.
  • Onset Rate: DKA develops acutely over $< 24\,\text{hours}$; HHS develops insidiously over days to weeks.
  • Blood Glucose Concentrations: DKA presents with blood glucose typically between $250\text{--}600\,\text{mg/dL}$; HHS presents with severe hyperglycemia, typically $> 600\,\text{mg/dL}$ (frequently exceeding $1{,}000\,\text{mg/dL}$).
  • Ketone Production and Acidosis:
    • DKA is characterized by absolute insulin deficiency, driving unrestrained lipolysis and hepatic ketogenesis, causing severe ketonemia, ketonuria, elevated anion gap metabolic acidosis ($\text{pH} < 7.30$, $\text{HCO}_3^- < 18\,\text{mEq/L}$), Kussmaul respirations, and a fruity acetone breath odor.
    • HHS retains sufficient endogenous insulin to prevent massive lipolysis and ketone synthesis; minimal or absent ketones are present, with normal arterial pH ($> 7.30$) and normal bicarbonate ($> 18\,\text{mEq/L}$).
  • Serum Osmolality and Dehydration: HHS exhibits extreme hyperosmolality ($> 320\,\text{mOsm/kg}$) and profound volume depletion ($8\text{--}10\,\text{L}$ fluid deficit) caused by sustained osmotic diuresis, producing prominent neurological deficits, lethargy, hemiparesis, seizures, and coma. DKA presents with moderate dehydration ($3\text{--}6\,\text{L}$ fluid deficit).

• Potassium Dynamics During DKA Therapy:

  • Prior to therapy, extracellular acidosis shifts potassium out of cells in exchange for hydrogen ions ($\text{H}^+$), while osmotic diuresis leads to urinary potassium wasting. Serum potassium may measure normal or elevated despite total-body potassium depletion.
  • Initiation of intravenous regular insulin therapy drives glucose and potassium back into the intracellular space.
  • Concurrently, intravenous fluid rehydration dilutes serum potassium, corrects hemoconcentration, and restores renal perfusion, enhancing urinary potassium excretion.
  • As acidosis resolves, potassium continues to move intracellularly, precipitating rapid and severe hypokalemia unless monitored and replaced early.

• Diabetic Self-Management:

  • Sick-Day Management: Continue baseline basal insulin administration; test blood glucose every $3\text{--}4\,\text{hours}$; check urine or blood for ketones when blood glucose is $> 240\,\text{mg/dL}$; consume small frequent meals or carbohydrate-containing fluids; maintain adequate fluid intake ($8\,\text{oz/hour}$); notify the healthcare provider for persistent fever, nausea/vomiting, elevated blood glucose unresponsive to supplemental insulin, or positive ketones.
  • Diabetic Foot Care (Sensory Neuropathy Prophylaxis): Inspect feet visually every day using a mirror; wash feet daily in lukewarm water and dry thoroughly, especially between the toes; avoid soaking feet; apply moisturizing lotion to dorsum and plantar surfaces but never between toes; never walk barefoot; wear well-fitting, closed-toe shoes; inspect inside shoes before wearing; cut toenails straight across; avoid heating pads or hot water bottles on feet.

• Clinical Analysis Examples:

  • Example 13 (Distinguishing Findings: DKA vs. HHS): DKA is defined by positive serum/urinary ketones, low arterial pH ($< 7.30$), low serum bicarbonate, rapid onset, and Kussmaul respirations with acetone breath. HHS is characterized by higher blood glucose levels ($> 600\,\text{mg/dL}$), marked hyperosmolality ($> 320\,\text{mOsm/kg}$), severe dehydration, the absence of ketoacidosis, and pronounced central nervous system alterations.
  • Example 14 (Risk of Normal Initial Serum Potassium in DKA): A normal initial serum potassium concentration is misleading because total-body potassium is depleted through osmotic diuresis. The impending administration of IV insulin and fluid resuscitation will drive potassium intracellularly, causing serum potassium levels to plummet rapidly and risking fatal cardiac dysrhythmias if potassium replacement is not initiated as soon as levels enter the normal range and urine output is established.

Cardiovascular Disorders: Hypertension, CAD, Angina, and Myocardial Infarction

• Ventricular Tachycardia Classifications:

  • Morphological Classification:
    • Monomorphic Ventricular Tachycardia: Features uniform, identical QRS complexes from beat to beat, arising from a single stable ectopic ventricular focus or re-entrant circuit.
    • Polymorphic Ventricular Tachycardia: Features continuously varying, irregular QRS configurations, indicating multiple shifting foci or unstable re-entry circuits (e.g., Torsades de Pointes, characterized by QRS complexes twisting around the isoelectric baseline, often associated with a prolonged QT interval).
  • Hemodynamic and Clinical Presentation Classification:
    • Pulseless Ventricular Tachycardia: Hemodynamically catastrophic arrest state with no palpable peripheral pulse; requires immediate defibrillation and cardiopulmonary resuscitation (CPR).
    • Unstable Ventricular Tachycardia (With a Pulse): Patient maintains a palpable pulse but presents with signs of severe hemodynamic instability (hypotension, chest pain, altered mental status, acute pulmonary edema); requires immediate synchronized cardioversion.
    • Stable Ventricular Tachycardia (With a Pulse): Patient maintains a palpable pulse, adequate blood pressure, and absence of severe end-organ hypoperfusion; managed with intravenous antiarrhythmic medications (e.g., amiodarone, procainamide, sotalol) under continuous ECG observation.

• Rapid Assessment of Suspected Acute Myocardial Infarction (AMI):

  • Clinical Manifestations: Substernal chest pressure, fullness, squeezing, or heaviness radiating to the left arm, neck, jaw, epigastrium, or back; diaphoresis; dyspnea; nausea/vomiting; lightheadedness; unexplained fatigue (often seen in women, older adults, and diabetic patients).
  • Vital Signs: Assess for tachycardia or bradycardia, hypotension or reactive hypertension, tachypnea, and decreased pulse oximetry.
  • 12-Lead Electrocardiogram (ECG): Obtain and interpret within $10\,\text{minutes}$ of arrival to distinguish:
    • ST-Segment Elevation Myocardial Infarction (STEMI): Acute transmural ischemia characterized by localized ST elevations ($\ge 1\,\text{mm}$ in two contiguous limb leads or $\ge 2\,\text{mm}$ in precordial leads) or new left bundle branch block; requires emergent reperfusion (percutaneous coronary intervention [PCI] within $90\,\text{minutes}$ of medical contact or fibrinolysis within $30\,\text{minutes}$ if PCI is unavailable).
    • Non-ST-Segment Elevation Myocardial Infarction (NSTEMI) / Unstable Angina: ST depression, T-wave inversion, or non-specific ST changes.
  • Cardiac Biomarkers: Serial cardiac troponin (Troponin I and Troponin T) tests are the gold standard for detecting myocardial necrosis. Levels rise within $3\text{--}4\,\text{hours}$ of injury and remain elevated for up to $10\text{--}14\,\text{days}$.

• Modifiable Coronary Artery Disease (CAD) Risk Factors:

  • Cigarette smoking and tobacco exposure.
  • Systemic arterial hypertension.
  • Dyslipidemia (elevated low-density lipoprotein cholesterol [LDL-C], elevated triglycerides, low high-density lipoprotein cholesterol [HDL-C]).
  • Diabetes mellitus and insulin resistance.
  • Physical inactivity and sedentary lifestyle.
  • Overweight/obesity (specifically visceral/abdominal adiposity).
  • Atherogenic diet (high saturated/trans fats, high sodium, refined sugars).

• Hypertensive Emergencies versus Isolated Blood Pressure Elevations:

  • Hypertensive Crisis Threshold: Systolic blood pressure $> 180\,\text{mm\,Hg}$ and/or diastolic blood pressure $> 120\,\text{mm\,Hg}$.
  • Hypertensive Urgency: Marked blood pressure elevation without acute, progressive target-organ damage. Managed with oral antihypertensives over hours to days.
  • Hypertensive Emergency: Severe blood pressure elevation accompanied by acute, life-threatening target-organ injury. Requires immediate admission to an intensive care unit and controlled intravenous antihypertensives (e.g., nicardipine, labetalol, sodium nitroprusside) to lower mean arterial pressure (MAP) by no more than $20\text{--}25\%$ within the first hour to prevent ischemic cerebral, myocardial, or renal hypoperfusion.
  • Signs of Target-Organ Injury: Hypertensive encephalopathy (altered mental status, severe headache, papilledema), acute stroke, acute coronary syndrome, acute left ventricular failure with pulmonary edema, aortic dissection, or acute renal failure.

• Pharmacotherapy Safety Considerations: